Find clinical trials for Pancreatic Cancer in Hanyang, Seoul
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Pancreatic Cancer trials near Hanyang, Seoul, KOR:
dose (MTD), safety and efficacy of BEY1107 in monotherapy and in combination with gemcitabine in patient With locally advanced or metastatic pancreatic...
Phase 1, Phase 2
Seoul, Korea, Republic of
as neoaduvant treatment in resectable or borderline resectable pancreatic cancer is feasible and efficacious.The combination of Dur...
Phase 2
Seoul, Korea, Republic of
Pancreatic cancer is the 8th most prevalent cancer in Korea, and its 5-year overall survival rate has shown less than 10% ...
Phase 1
Seoul, Seoul, South Korea
Antroquinonol is proposed for the treatment of neoplasms. The proposed clinical trial is a Phase I/II study designed to evaluate antroquinon ...
Phase 1, Phase 2
Seoul, Korea, Republic of and 8 other locations
Zolbetuximab is being studied as a treatment for people with pancreatic cancer. Most people with pancreatic cancer...
Phase 2
Seoul, Korea, Republic of and 135 other locations
ACCENT: AMP945 in Combination with Nab-paclitaxel and Gemcitabine for Treatment of Pancreatic Cancer
to therapy in first-line patients with unresectable or metastatic pancreatic cancer.Part A is a phase 1b dose-escalation design tha...
Phase 1, Phase 2
Seoul, Korea, Republic of and 12 other locations
combination with modified FOLFIRINOX (mFOLFIRINOX) or Gemcitabine-nab-paclitaxel (GemAbraxne) in patients with locally advanced and metastatic pancreatic...
Phase 1
Seoul, Korea, Republic of and 3 other locations
of adjuvant Immuncell-LC therapy combined with gemcitabine versus adjuvant gemcitabine single therapy after R0 or R1 resection in patients with pancreatic...
Phase 3
Seoul, Daehak-ro, Jongno-gu, Korea, Republic of
or without SBP-101 in subjects previously untreated for metastatic pancreatic ductal adenocarcinoma (PDA), including subjects who have recei...
Phase 2, Phase 3
Seoul, Seoul Teugbyeolsi, Korea, Republic of and 91 other locations
A Phase Ib/II, open-label, multicenter, randomized study designed to assess the safety, tolerability, pharmacokinetics and preliminary anti-tumor...
Phase 1, Phase 2
Seoul, Korea, Republic of and 18 other locations
Clinical trials
Research sites
Resources
Legal